Brief: aTyr Pharma Q4 Net Income USD -14.761 Million
14/03/2024 20:00
Mar 14 (Reuters) - aTyr Pharma Q4 basic EPS USD -0.25. * Q4 income from operations USD -15.959 million * Q4 operating expenses USD 15.959 million
Recent news on aTyr Pharma
See all newsBrief: Atyr Pharma Announces Research Collaboration With Montefiore Einstein
U.S. STOCKS ON THE MOVE-Charles River, Oracle, TD Synnex
US STOCKS ON THE MOVE-Charles River, Oracle, TD Synnex
U.S. STOCKS ON THE MOVE-CoreWeave, Versant Media, BlackBerry
aTyr rises as FDA aligns on late-stage lung disease study plan